ﻻ يوجد ملخص باللغة العربية
Quantitatively predicting phenotype variables by the expression changes in a set of candidate genes is of great interest in molecular biology but it is also a challenging task for several reasons. First, the collected biological observations might be heterogeneous and correspond to different biological mechanisms. Secondly, the gene expression variables used to predict the phenotype are potentially highly correlated since genes interact though unknown regulatory networks. In this paper, we present a novel approach designed to predict quantitative trait from transcriptomic data, taking into account the heterogeneity in biological samples and the hidden gene regulatory networks underlying different biological mechanisms. The proposed model performs well on prediction but it is also fully parametric, which facilitates the downstream biological interpretation. The model provides clusters of individuals based on the relation between gene expression data and the phenotype, and also leads to infer a gene regulatory network specific for each cluster of individuals. We perform numerical simulations to demonstrate that our model is competitive with other prediction models, and we demonstrate the predictive performance and the interpretability of our model to predict alcohol sensitivity from transcriptomic data on real data from Drosophila Melanogaster Genetic Reference Panel (DGRP).
One of the classic concerns in statistics is determining if two samples come from thesame population, i.e. homogeneity testing. In this paper, we propose a homogeneitytest in the context of Functional Data Analysis, adopting an idea from multivariate
We develop a new methodology for spatial regression of aggregated outputs on multi-resolution covariates. Such problems often occur with spatial data, for example in crop yield prediction, where the output is spatially-aggregated over an area and the
In the process of clinical diagnosis and treatment, the restricted mean survival time (RMST), which reflects the life expectancy of patients up to a specified time, can be used as an appropriate outcome measure. However, the RMST only calculates the
We develop a distribution-free, unsupervised anomaly detection method called ECAD, which wraps around any regression algorithm and sequentially detects anomalies. Rooted in conformal prediction, ECAD does not require data exchangeability but approxim
Competing risks data are common in medical studies, and the sub-distribution hazard (SDH) ratio is considered an appropriate measure. However, because the limitations of hazard itself are not easy to interpret clinically and because the SDH ratio is